First Page PDF

Download as pdf or txt
Download as pdf or txt
You are on page 1of 1

7

Section
AIRWAY DISEASES

Chapter 41
Chronic Obstructive Pulmonary Disease:
Epidemiology, Pathophysiology, and
Clinical Evaluation
William MacNee

Chronic obstructive pulmonary disease (COPD) is a prevent- their airflow limitation. Indeed, some patients with asthma may
able and treatable chronic lung condition characterized by develop COPD, or these two common conditions may coexist
airflow limitation that is not fully reversible. COPD is increas- in the same individual. Therefore the problem often is not
ingly recognized as a major global problem that places a burden whether the patient has asthma or COPD, but rather whether
on both patients who suffer from this disabling condition and either asthma or COPD is present.
health care resources. Despite significant advances in our Chronic bronchitis is defined clinically by the American Tho-
understanding of the pathogenesis, physiology, clinical features, racic Society (ATS) and the United Kingdom (UK) Medical
and management of COPD in recent years, much remains to Research Council as “the production of sputum on most days
be discovered about this condition. for at least three months in at least two consecutive years when
Although hidden by the generic term “chronic obstructive a patient with another cause of chronic cough has been
pulmonary disease,” COPD is a heterogeneous collection of excluded.” This definition does not require the presence of
syndromes with overlapping manifestations, which has led to airflow limitation. Chronic bronchitis results from inflamma-
major difficulties in obtaining an acceptable definition of the tion in the larger airways, with bronchial gland hypertrophy
condition. In addition, as with many chronic inflammatory and mucus cell hyperplasia.
conditions, COPD is associated with extrapulmonary effects Emphysema is defined pathologically as “abnormal, perma-
and comorbidities that affect both morbidity and mortality. nent enlargement of the distal air spaces, distal to the terminal
The acceptance that symptoms of breathlessness, cough, and bronchioles, accompanied by destruction of their walls and
sputum production are part of aging or an inevitable conse- without obvious fibrosis.” As with chronic bronchitis the defini-
quence of cigarette smoking, and not related to a disease, results tion of emphysema does not require the presence of airflow
in underdiagnosis despite the diagnosis of COPD being easily limitation. As emphysema progresses, the consequent loss
made. This underdiagnosis is exacerbated by the belief, rein- of lung elastic recoil contributes to the airflow limitation
forced by many definitions, that COPD is an “irreversible” in COPD.
condition and that there is nothing “to reverse” with treat- Bronchiolitis or small airways disease also occurs in COPD,
ment. This leads not only to underdiagnosis but also to where chronic inflammation in the smaller bronchi and bron-
undermanagement. chioles less than 2 mm in diameter leads to airway remodeling,
It is now well recognized that significant responses to treat- resulting in airflow limitation. Although relatively little is
ment do occur, which has led to a much more positive approach known of the natural history, bronchiolitis may contribute
to the diagnosis and treatment of COPD. Whereas previous increasingly, as it progresses, to the airflow limitation in COPD.
treatments largely focused on patients at the severe end of the The relative contributions made by large or small airways
disease spectrum, recent guidelines recognize that diagnosis abnormalities or emphysema to the airflow limitation, in indi-
and treatment at an earlier stage can offer significant benefits vidual patients with COPD, is difficult to determine. Thus the
for patients. Although unable to cure COPD, current treat- term “chronic obstructive pulmonary disease” was introduced
ments can reduce symptoms, improve function, and reduce in the 1960s to describe patients with incompletely reversible
exacerbations in patients as well as decrease the enormous airflow limitation caused by a combination of airways disease
health care costs associated with COPD. and emphysema, without defining the contribution of these
conditions to the airflow limitation.
In the statement on the standards for diagnosis and care of
DEFINITIONS AND DIAGNOSTIC CONSIDERATIONS
patients with COPD by ATS and European Respiratory Society
In defining COPD, several problems must be considered. First, (ERS), COPD is defined as “a preventable and treatable disease
COPD is not just one disease but a group of diseases. Second, state characterized by airflow limitation that is not fully revers-
it is difficult to differentiate COPD from asthma; the persistent ible. The airflow limitation is usually progressive and is associ-
airways obstruction in older patients with chronic asthma is ated with an abnormal inflammatory response in the lungs to
often difficult or even impossible to distinguish from that of noxious particles or gases, primarily caused by cigarette smoking.
COPD patients, who may demonstrate partial reversibility of Although COPD affects the lungs, it also produces significant

531

You might also like